Lung cancer rate predictions using generalized additive models
Open Access
- 14 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Biostatistics
- Vol. 6 (4) , 576-589
- https://doi.org/10.1093/biostatistics/kxi028
Abstract
Predictions of lung cancer incidence and mortality are necessary for planning public health programs and clinical services. It is proposed that generalized additive models (GAMs) are practical for cancer rate prediction. Smooth equivalents for classical age-period, age-cohort, and age-period-cohort models are available using one-dimensional smoothing splines. We also propose using two-dimensional smoothing splines for age and period. Variance estimation can be based on the bootstrap. To assess predictive performance, we compared the models with a Bayesian age-period-cohort model. Model comparison used cross-validation and measures of predictive performance for recent predictions. The models were applied to data from the World Health Organization Mortality Database for females in five countries. Model choice between the age-period-cohort models and the two-dimensional models was equivocal with respect to cross-validation, while the two-dimensional GAMs had very good predictive performance. The Bayesian model performed poorly due to imprecise predictions and the assumption of linearity outside of observed data. In summary, the two-dimensional GAM performed well. The GAMs make the important prediction that female lung cancer rates in these countries will be stable or begin to decline in the future.Keywords
This publication has 3 references indexed in Scilit:
- Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and ControlJNCI Journal of the National Cancer Institute, 2003
- Prediction of cancer incidence in the Nordic countries: empirical comparison of different approachesStatistics in Medicine, 2003
- Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?Annals of Oncology, 2003